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The small 11-kDa proteins of B19 parvovirus contain three proline-rich regions which conform to consensus Src homology
3 (SH3) ligand sequences present in signaling molecules within the cell. We have shown that the B19 11-kDa proteins
specifically interact with the growth factor receptor-binding protein 2 (Grb2) in vitro. Mutation of prolines within one of the
three SH3 ligand-like sequences decreases the binding of B19 11-kDa proteins to Grb2, suggesting that the proline-rich
region is involved in the B19 11-kDa/Grb2 interaction. Therefore, the B19 11-kDa proteins may function to alter Grb2-mediated
signaling by disrupting SH3 domain/ligand interactions. These results implicate the 11-kDa proteins in B19 pathogenesis
through perturbation of normal cellular signaling pathways. © 2001 Elsevier Science
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B19 human parvovirus has been identified as the
causative agent of erythema infectiosum causing a char-
acteristic “slapped cheek rash.” B19 infection in adults,
especially women, often leads to arthritis-like joint com-
plications. These and other symptoms associated with
B19 infection are transient and self-resolve within days
or weeks in healthy, immunocompetent individuals. The
B19 virus targets progenitor cells of the erythroid lineage,
causing a life-threatening transient aplastic crisis in in-
dividuals with an underlying hemological disorder. The
virus can also establish chronic infection in those indi-
viduals with congenital or acquired immunodeficiencies,
and intrauterine infection by B19 has been implicated in
multiple cases of hydrops fetalis or spontaneous abor-
tion resulting from severe anemia of the fetus (reviewed
in Rogers, 1999).
A number of primary cell lines will support B19 repli-
cation when supplemented with erythropoietin, but these
culture systems are not readily amenable to experimen-
tal manipulation. In the absence of a continuous permis-
sive cell line for propagating B19, the use of transfected
cell systems has aided in the elucidation of various
molecular and cellular aspects of B19 replication and
transcription. Recent research has focused on the func-
tions of B19 nonstructural proteins and the roles they
play in the viral life cycle and pathogenesis. B19 directs
1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (604) 822-5227. E-mail: astell@interchange.ubc.ca.
285expression of all of its transcripts from a single promoter
at map unit 6 (p6) (Blundell et al., 1987; Doerig et al., 1987;
Ozawa et al., 1987) and the major nonstructural protein,
NS, is believed to be responsible for mediating much of
B19 pathogenicity likely via induction of apoptosis (Mof-
fatt et al., 1998). The B19 parvovirus also produces a
family of nonstructural 11-kDa proteins (St. Amand et al.,
1991; St. Amand and Astell, 1993).
Analysis of the amino acid sequence of the 11-kDa
proteins (Fig. 1a) indicates an unusually high proportion
of proline residues: 14 of 94 residues or 15%. Twelve of
the 14 proline residues can be grouped into three re-
gions which share similarity with sequences known to
bind to Src homology 3 (SH3)2 domains in a variety of
signal-transducing molecules (Fig. 1b). These regions
and domains belong to a large, diverse family of non-
catalytic, folding protein modules which provide a basic
building block in receptor tyrosine kinase (RTK) signal-
ing. These domains mediate moderate- to high-affinity
binding between proteins to form multicomponent com-
plexes that enable extracellular signals to be propagated
to the interior of the cell, to elicit highly specialized
2 Abbreviations used: DEAE, diethylaminoethyl; DMEM, Dulbecco’s
modified Eagle’s medium; DMSO, dimethylsulfoxide; EGFP, enhanced
green fluorescent protein; GST, glutathione S-transferase; HA, hemag-
glutinin; HEK, human embryonal kidney; ORF, open reading frame; PBS,
phosphate-buffered saline; PVDF, polyvinylidene difluoride; RTK, recep-
tor tyrosine kinase; SDS–PAGE, sodium dodecyl sulfate–polyacrylam-
ide gel electrophoresis; SH3, Src homology 3; Sos, son of sevenless;
wt, wild-type.
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286 FAN ET AL.biological responses from the cell (reviewed in Mayer
and Gupta, 1998). The presence of SH3 ligand-like re-
gions within the B19 11-kDa sequence led us to specu-
late that the B19 11-kDa proteins may be involved in
binding to cellular proteins via their proline-rich regions.
Preliminary evidence from glutathione S-transferase (GST)
affinity chromatography experiments in our laboratory has
suggested that at least two cellular proteins (of MW 85 and
26 kDa) from a human leukemic cell lysate are capable of
binding the B19 11-kDa proteins (D. B. Zagrodney and
C. R. Astell, unpublished observations).
In the present study, we demonstrate that the B19
11-kDa protein specifically interacts in vitro with the
growth factor receptor-binding protein 2 (Grb2), an adap-
tor protein implicated in RTK-mediated signaling of mito-
genic and stress stimuli. We also show that the 11-kDa
protein binds Grb2 in an SH3 domain/ligand-dependent
manner. Our findings implicate the 11-kDa proteins in
B19 pathogenesis through perturbation of normal cellular
signaling pathways by binding Grb2 or another as yet
unidentified SH3 domain-containing protein. In this re-
port, the longest (94 aa) 11-kDa protein is fused to GST or
enhanced green fluorescent protein (EGFP) at the C-
terminus. Within the text, we normally refer to the 11-kDa
protein as a single species as the family of three 11-kDa
proteins results due to use of three, in-frame, AUG
codons (St. Amand and Astell, 1993), which would not
occur in our fusion constructs.
RESULTS
B19 11-kDa proteins associate with Grb2 adaptor
protein by far-Western blot analyses
FIG. 1. (A) Amino acid sequence of the B19 11-kDa protein. Proline-
rich regions corresponding to consensus SH3-binding sites are high-
lighted. (B) Amino acid sequence alignment of selected proline-rich
SH3-binding motifs in B19 11-kDa proteins and human Sos (hSos).
Conserved proline residues are highlighted.The B19 11-kDa proteins contain 15% proline residues,
including three regions conforming to the consensusxPPxPxx SH3-binding site motif (Fig. 1A). The second
region, located at position 41–47, exhibits striking simi-
larities to the SH3 ligands present in the guanine nucle-
otide exchange factor son of sevenless (Sos) (Fig. 1B).
Because Sos uses such SH3 ligands to bind to SH3
domain-containing proteins such as the Grb2 adaptor
protein, we investigated whether the B19 11-kDa proteins
could also bind Grb2. We used GST, GST–11, GST–hem-
agglutinin (HA), and GST–HA–Grb2 fusion proteins in
far-Western studies to determine whether the B19 11-kDa
proteins could interact with Grb2. Affinity-purified frac-
tions of GST and GST–11 were resolved by sodium do-
decyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE), transferred to polyvinylidene difluoride (PVDF)
membrane, probed with either GST–HA or GST–HA–
Grb2, and detected using an anti-HA antibody (Fig. 2).
Results suggest that GST–HA–Grb2 binds to membrane-
bound GST–11 but not GST, confirming specificity of the
interaction of the Grb2 fusion protein with the 11-kDa
moiety of GST–11. Neither GST nor GST–11 binds to
GST–HA, indicating that GST–11 interacts specifically
with the Grb2 portion of the GST–HA–Grb2 fusion pro-
tein.
FIG. 2. B19 11-kDa proteins associate with Grb2 adaptor protein by
far-Western blotting. Affinity-purified protein preparations of GST and
GST–11 were resolved by 12.5% SDS–PAGE, transferred to PVDF mem-
brane, and subjected to either Western blotting with an anti-GST anti-
body at 1:10,000 dilution (left) or far-Western blotting (center and right).
For far-Western blotting, the membranes were first incubated with a
protein probe consisting of either resin-purified GST–HA (center) or
resin-purified GST–HA–Grb2 (right) diluted in blocking buffer to a final
concentration of 1.0 mg/ml. Any bound GST–HA or GST–HA–Grb2 was
subsequently detected using an anti-HA antibody at a 1:5000 dilution
using the Western blotting protocol.
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kDa proline-rich region
Because the B19 11-kDa proteins contain regions
conforming to SH3 ligands similar to those employed
by Sos to interact with Grb2, we postulated that the
association between Grb2 and the 11-kDa protein may
also be dependent on SH3 domain/ligand interactions.
To examine the requirement for specific proline resi-
dues in the Grb2/11-kDa interaction, constructs encod-
ing GST–11 with proline-to-alanine mutations within
the second proline-rich region (position 41–47) were
created by site-directed mutagenesis. GST–11 mu-
tants were tested alongside wild-type (wt) GST–11, and
GST in far-Western studies as described above (Figs.
3A–3C). Our findings indicate that GST–HA–Grb2
binds with reduced affinity to membrane-bound
GST–11 proteins mutated in certain proline residues,
as compared with wt GST–11. While the binding of
Grb2 to GST–11 is not greatly affected by single mu-
tations at proline residues 43 or 46, mutations at
residues 42 and 45 do have an effect and multiple
mutations in the GST–11 protein appear to significantly
reduce the interaction. These results strongly suggest
that this proline-rich region is involved in mediating
interactions of the 11-kDa protein with Grb2 in far-
Western experiments.
B19 11-kDa proteins associate with Grb2 adaptor
protein in a GST pull-down assay in a SH3 domain/
ligand-dependent manner
To further confirm our hypothesis, we investigated the
ability of the B19 11-kDa proteins to precipitate soluble,
endogenous Grb2 from a mammalian cell lysate. A GST
pull-down assay was carried out to assess the interac-
tion of soluble GST, GST–11, and GST–11 mutants with
cellular Grb2. Purified GST or GST fusion proteins were
incubated with human embryonic kidney (HEK) 293 cell
lysate in the presence of glutathione–Sepharose resin.
GST, GST–11 wt/mutants, and any associated proteins
were collected with the resin by centrifugation and ana-
lyzed by SDS–PAGE (Figs. 3D and 3E). Our findings show
that cellular Grb2 is effectively coprecipitated by GST–11
but not by GST, further providing support for an interac-
tion between Grb2 and the 11-kDa proteins. GST–11
proteins mutated in certain proline residues exhibit re-
duced binding to Grb2, as compared with wt GST–11.
Single mutations at proline positions 43 or 46 do not
appear to interfere with the ability of GST–11 to copre-
cipitate Grb2 while mutations at positions 42 and 45 as
well as multiple mutations do interfere. These results
parallel those from the far-Western blotting experiments
and provide strong support that the second proline-rich
region of the 11-kDa proteins is involved in mediating the
Grb2/11-kDa interaction.Preferential interaction of the EGFP–11-kDa fusion
protein expressed in COS-7 cells with cellular Grb2
To establish a fully in vivo system in which the 11-kDa
protein might be shown to interact with cellular Grb2,
COS-7 cells were transfected with a plasmid (pEGFP-11)
expressing an EGFP–11-kDa fusion protein or with the
control vector (pEGFP-C2) expressing EGFP. The effi-
ciency of transfection varied with the EGFP plasmid
used, yielding an ;20-fold higher transfection efficiency
for pEGFP-C2 than for pEGFP-11. Hence, lysates of
EGFP-expressing cells were diluted accordingly with
nontransfected lysate to match levels of EGFP–11 ex-
pression in pEGFP-11-transfected cells. (The levels of
EGFP–11 and EGFP were estimated by comparing the
number of fluorescing cells expressing EGFP or EGFP–
11. Since the cells expressing EGFP were often brighter
than the EGFP–11-positive cells, this method likely un-
derestimates the level of EGFP.) Lysates were incubated
with anti-Grb2 antibody and precipitated with protein
A–Sepharose resin. Proteins which bound to the anti-
body were analyzed by SDS–PAGE and Western blotting
(Fig. 4). We find that in our hands both EGFP and
EGFP–11 were immunoprecipitated under the conditions
tested; however, there appears to be enhanced binding
of EGFP–11, as suggested by the increased signal inten-
sity of the band corresponding to EGFP–11 compared
with EGFP in the immunoprecipitation samples after cor-
recting for transfection efficiency differences.
DISCUSSION
This study provides in vitro evidence in support of our
hypothesis that the small 11-kDa proteins produced by
parvovirus B19 may play a role in the viral life cycle by
interfering with the host environment through its interac-
tions with cellular signaling molecules such as Grb2 or
other SH3 domain-containing proteins. The binding of
Grb2 to the 11-kDa protein may perturb the normal func-
tion of the Grb2 adaptor in binding the guanine nucleo-
tide exchange factor Sos. Interaction of Grb2 with Sos
involves the binding of proline-rich SH3 ligands in Sos
with the cognate SH3 domains in Grb2. The B19 11-kDa
proteins also contain similar proline-rich regions, which
led to the hypothesis that the binding of Grb2 to the
11-kDa protein may be mediated by the same types of
SH3 domain/ligand interactions as those responsible for
Grb2/Sos interactions during normal host signaling.
Ten mutants of GST–11 in which one or more proline
residues were selectively replaced by alanine residues
were tested alongside GST and GST–11 in far-Western
and GST pull-down experiments to determine the re-
quirements of the 11-kDa/Grb2 interaction for the second
proline-rich region in the 11-kDa proteins. It is known that
SH3 ligand peptides can potentially bind in either orien-
tation and the proline-rich sequences are known to exist
in a left-handed polyproline type II helix (Pawson, 1995).
PVDF m
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the ability to interact with GST–HA–Grb2, while reduced
interactions are observed with the P42A and P45A mu-
tants and markedly reduced interactions are observed
FIG. 3. The 11-kDa/Grb2 interaction in vitro requires the 11-kDa
Affinity-purified protein preparations of GST, GST–11, and GST–11 muta
subjected to either far-Western blotting (A) or Western blotting (B and
probe consisting of resin-purified GST–HA–Grb2 diluted in blocking
subsequently detected using an anti-HA antibody at a 1:5000 dilution.
antibody (B) or an anti-11-kDa antibody (C) at 1:10,000 dilution. In B, the
as two proteolytic degradation products (32 and 30 kDa). These prot
predominantly the full-length 37-kDa band. For GST pull-down experim
GST–11 mutants in the presence of glutathione–Sepharose resin. Any
pull-down samples were resolved by 12.5% SDS–PAGE, transferred to
antibody (D) or an anti-GST antibody (E) at a 1:10,000 dilution. The larfor several of the double and triple mutants. These re-
sults demonstrate that, while no single proline residue iscritical for SH3 binding, multiple prolines together con-
tribute to the interaction. Our findings provide strong
support for the involvement of the second proline-rich
SH3 ligand-like region of the B19 11-kDa proteins as a
e-rich region in far-Western blots and GST pull-down experiments.
re resolved by 12.5% SDS–PAGE, transferred to PVDF membrane, and
far-Western blotting, the membrane was first incubated with a protein
o a final concentration of 0.5 mg/ml. Any bound GST–HA–Grb2 was
stern blotting, the membranes were detected with either an anti-GST
11 affinity-purified protein included a full-length 37-kDa protein as well
pear to have lost the 11-kDa portion as anti-11-kDa protein detects
EK 293 cell lysates were incubated with resin-purified GST, GST–11, or
cting proteins were coprecipitated upon centrifugation. Proteins from
embrane, and subjected to Western blotting with either an anti-Grb2
d at 26 kDa is cellular GST.prolin
nts we
C). For
buffer t
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lar Grb2 in vitro suggests a possible mechanism of B19
parvovirus to manipulate the host cell environment by
modulating signaling pathways, thereby affecting down-
stream signaling events including those stemming from
mitogenic stimuli. Examples of virally encoded nonstruc-
tural proteins which interact with SH3 domain proteins
and/or disrupt mitogenic signaling include the hepatitis
C virus NS5A protein (Tan et al., 1999) and the human
immunodeficiency virus type 1 Nef protein (Saksela et al.,
1995; Manninen et al., 1998), both of which are implicated
in modulation of host signaling cascades involved in
virulence and pathogenesis. The B19 11-kDa proteins
may function in a similar way to enhance viral replication
and propagation.
Having established the involvement of at least one of
the three proline-rich sequences of the 11-kDa proteins
in binding to Grb2, in vitro, in far-Western and GST pull-
down experiments, it will be instructive to mutate the
remaining two regions individually or in combination to
examine the requirement for and possible synergistic or
compensatory effects of these proline-rich regions in the
Grb2/11-kDa interaction.
Although we have demonstrated preferential interac-
tion of EGFP–11 with cellular Grb2, the in vivo relevance
of this interaction remains uncertain. Previously, we have
shown that the 11-kDa proteins are predominantly, al-
FIG. 4. An EGFP–11-kDa fusion protein expressed in COS-7 cells
interacts preferentially with cellular Grb2. Undiluted (EGFP- and EGFP–
11-expressing) or 25-fold diluted (EGFP-expressing) cell lysates from
transfected COS-7 cells were incubated with an anti-Grb2 antibody in
the presence of protein A–Sepharose. Any interacting proteins were
coimmunoprecipitated upon centrifugation. Proteins from lysates and
immunoprecipitation samples were resolved by 12.5% SDS–PAGE,
transferred to PVDF membrane, and subjected to Western blotting with
either an anti-Grb2 antibody (A) or an anti-GFP antibody (B).though not exclusively, nuclear (W. Luo and C. R. Astell,
unpublished data). Grb2 is predominantly cytoplasmic,although importantly up to 20% can be located in the
nucleus (Romero et al., 1998). However, many proteins
have SH3 domains and one or more of these proteins
may be important cellular interactors. We have tested a
second adaptor protein, Crk II, in GST pull-down exper-
iments and observed nonspecific interactions of Crk II
with both GST and GST–11 with no evidence of prefer-
ential interaction with GST–11, indicating that not every
SH3 domain protein is able to interact with the 11-kDa
proteins (data not shown). Crk II has both SH2 and SH3
domains. It is phosphorylated in response to Epidermal
Growth Factor (EGF) stimulation and the phosphorylated
form appears to dissociate from the EGF receptor
(Hashimoto et al., 1998). Other SH3 domain-containing
proteins also need to be tested for their ability to interact
specifically with the 11-kDa proteins. We may be able to
scale up the GST–11 affinity purification of cellular inter-
acting proteins (D. B. Zagrodney and C. R. Astell, unpub-
lished data) in order to identify these proteins using
mass spectrometry (Link et al., 1999). An alternate ap-
proach may be to use a method of panning of domain
cDNA libraries displayed on the surface of phage to
identify other potential interacting proteins (Zucconi et
al., 2001).
MATERIALS AND METHODS
Plasmids and mutagenesis
pGEX2T (Pharmacia) directs expression in Escherichia
coli of GST, a 26-kDa protein from Schistosoma japoni-
cum, under the control of the inducible tac promoter. GST
and GST fusion proteins can be purified by affinity chro-
matography on glutathione–Sepharose resin. pGEX-11
(constructed by J. St. Amand) contains the B19 11-kDa
open reading frame (ORF) (Fig. 1a) cloned in-frame into
the BamHI/EcoRI sites of pGEX2T. This vector directs the
expression of a GST–11-kDa fusion protein, GST–11.
pGEX-11 plasmids containing proline-to-alanine muta-
tions in the 11-kDa ORF (pGEX-11 P42,45A; P42,45,46A;
P42,46A; P43A; P43,45A; P43,45,46A; P45A; and P45,46A)
were constructed by PCR-based site-directed mutagen-
esis using complementary degenerate oligonucleotide
primers, 11kDPro2 (59-cag gta cag tct gg(c/g) tg(c/g) tac
tg(c/g) tg(c/g) gcg ttt agt tac-39) and 11COMPL (59-gta act
aaa cgc (c/g)ca (c/g)ca gta (c/g)ca (c/g)cc aga ctg tac
ctg-39). These primers are partially degenerate at the first
nucleotide position of each triplet corresponding to the
four proline residues targeted for mutation (Pro-42,43,45,
and 46). pGEX-11 P42A and pGEX-11 P46A were similarly
constructed from pGEX-11 by PCR-based site-directed
mutagenesis using complementary oligonucleotide
primer pairs, P42A1 (59-cgt aac taa acg cgc acc agt acc
acc-39)/P42A2 (59-ggt ggt act ggt gcg cgt tta gtt acg-39)
and P46A1 (59-gcc cac cag tac cag cca gac tgt acc
tg-39)/P46A2 (59-cag gta cag tct ggc tgg tac tgg tgg gc-39),
respectively. Nucleotide mutations corresponding to the
290 FAN ET AL.specified amino acid changes are set in bold. Mutated
pGEX-11 vectors direct expression in bacteria of mutant
GST–11 fusion proteins. pGEX2T-tag (gift from K. Harder)
was constructed by insertion of a HA epitope tag and
polylinker into the BamHI/EcoRI sites of pGEX2T. This
plasmid expresses a GST–HA fusion protein. pGEX2T-
tag-Grb2 (gift from K. Leslie and M. Welham) was con-
structed by cloning the cDNA encoding human Grb2 into
the NheI/EcoRI sites of pGEX2T-tag. This vector directs
the expression of a GST–HA–Grb2 fusion protein.
pEGFP-C2 (Clontech) directs expression in mammalian
cells of EGFP, under the control of a human cytomega-
lovirus immediate-early promoter. pEGFP-11 (construct-
ed by H. Chen) contains the B19 11-kDa ORF cloned
in-frame into the BglII/EcoRI sites of pEGFP-C2. This
vector directs the expression of an EGFP–11-kDa fusion
protein, EGFP–11.
Protein expression and purification
GST and GST fusion proteins were expressed in
DH10b E. coli and purified according to the manufactur-
er’s protocol.
Far-Western and Western blotting
Whole-cell lysates, precipitated proteins, or purified
GST and GST fusion proteins were subjected to SDS–
PAGE and transferred to PVDF membranes (Bio-Rad or
Pall Corp.). Membranes were probed with specific pri-
mary antibodies and the appropriate horseradish perox-
idase-conjugated secondary antibodies. Proteins of in-
terest were visualized by enhanced chemiluminescence
(Amersham Pharmacia Biotech). For far-Western blotting,
2 mg of GST, GST–11, and GST–11 mutant proteins was
resolved by SDS–PAGE and transferred to PVDF mem-
branes. The procedure is essentially identical to that of
Western blotting except for an additional incubation with
a protein probe solution containing 0.5–1.0 mg/ml
GST–HA or GST–HA–Grb2 dissolved in blocking buffer,
prior to detection with an antibody directed against the
HA epitope (Boehringer Mannheim).
Cell lines
COS-7 and HEK 293 cells were cultured as monolay-
ers in complete medium consisting of low-glucose Dul-
becco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum and 10 mM N-[2-
hydroxyethyl]piperazine-N9-[2-ethanesulfonic acid] at pH
7.4, 37°C, and 5% CO2. Cells were routinely trypsinized
and passaged in a 1:10 dilution in fresh medium when
they reached about 90% confluency, usually every 3 to 4
days.
TransfectionCOS-7 cells were transfected by a modified diethyl-
aminoethyl (DEAE)–dextran procedure. Briefly, nearlyconfluent cells in 100-mm culture dishes were passaged
at a 1:6 dilution 1 day prior to transfection. Five micro-
grams of plasmid DNA purified by ethanol precipitation
was dissolved in 100 ml of sterilized distilled H2O, mixed
with 200 ml of 2 mg/ml DEAE–dextran, and diluted to a
3-ml final volume with serum-free DMEM. Cells were
washed twice with additive-free DMEM and then over-
laid with the transfection solution. After 8 h of incubation
at 37°C and 5% CO2, the transfection solution was re-
moved and replaced with 3 ml of phosphate-buffered
saline (PBS) containing 10% dimethylsulfoxide (DMSO).
Cells were subjected to the DMSO shock for exactly 5
min and then washed twice with PBS before the addition
of 10 ml of complete medium. Transfected cells were
incubated at 37°C, 5% CO2 for 2 days before being
harvested for immunoprecipitation experiments.
Lysate preparation
For the GST fusion protein pull-down assays and im-
munoprecipitation experiments, nearly confluent cells
were washed once in PBS and resuspended at a con-
centration of ;3 3 106 cells per milliliter of 20 mM
Tris–Cl, pH 7.4, supplemented with 2 mg/ml antipain, 0.5
mM phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin,
and 4 mg/ml aprotinin. Cells were lysed by Dounce ho-
mogenization after a 15-min incubation on ice. The nuclei
were pelleted and the supernatant was stored on ice and
used within 2 h.
GST protein pull-down assay
GST protein pull-down assays were performed accord-
ing to a protocol similar to that described in Byrne et al.
(1996). Briefly, 500 ml of Dounce homogenized HEK 293
cell lysate (;0.5–1.0 mg protein) was incubated with
end-to-end rotation for 2 h at 4°C with a 10-ml bed
volume of PBS-equilibrated glutathione–Sepharose 4B
resin (Amersham Pharmacia Biotech), in the presence of
10 mg of affinity-purified GST or GST fusion protein. The
resin and associated proteins were washed three times
with ice-cold PBS and analyzed by Western blot as de-
scribed above.
Immunoprecipitation
The protocol for immunoprecipitation studies was de-
rived from the method described by Bonifacino et al.
(1999). Briefly, 500 ml of Dounce homogenized lysate
(;0.5–1.0 mg protein) from COS-7 cells transfected with
pEGFP-11 or with pEGFP-C2 (diluted 25-fold to match
EGFP–11 levels) was incubated with end-to-end rotation
for 2–3 h at 4°C with a 15-ml bed volume of equilibrated
protein A–Sepharose CL-4B resin (Amersham Pharmacia
Biotech) which was previously bound to 0.5–1.0 mg rabbit
anti-Grb2 polyclonal antibody (StressGen Biotechnolo-
gies) in the presence of 0.1 mg bovine serum albumin in
20 mM Tris–Cl, pH 7.4, for 1 h at 4°C. The resin and
291B19 11-kDa PROTEINS BIND Grb2 IN VITROassociated proteins were washed twice with 20 mM
Tris–Cl, pH 7.4, and analyzed by Western blotting using a
mouse anti-green fluorescent protein monoclonal anti-
body (StressGen Biotechnologies).
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